2nd Quarter - Report — MAYO CLINIC for MAYO CLINIC (2016)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$280,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Railroads RRR

High Speed Rail; Freight Rail Corridor

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Vice President of the U.S.; Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Transportation, Dept of (DOT); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Health Issues HCR

Hospital Payments, Physician Payments, Healthcare Grants, Stark/anti-trust, Telemedicine, ICD-10, LDTs, HIPAA

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: Vice President of the U.S.; White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; Transportation, Dept of (DOT); Natl Institutes of Health (NIH)

Science/Technology SCI

Telemedicine; Medical Device Technologies; New Diagnostic Tests; Precision Medicine; Cancer Moonshot

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Vice President of the U.S.; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Teaching hospital payments; ACOs; CMMI; Quality Issues; Telemedicine; 340B Program; Drug Pricing.

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Vice President of the U.S.; White House Office; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding; Precision Medicine; Cancer Moonshot

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: Natl Institutes of Health (NIH); White House Office; Transportation, Dept of (DOT); SENATE; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.